Primary Cutaneous Non-Hodgkin Lymphoma — Trials

Primary Cutaneous Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

352 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01177371	High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma	completed	Phase 2	13	Case Comprehensive Cancer CenterOTHER	1	Aug 9, 2010	clinicaltrials
NCT01132989	Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma(REvMM2009)	unknown	Phase 2	10	Florida Academic Dermatology CentersOTHER